Detalhe da pesquisa
1.
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
N Engl J Med
; 388(15): 1353-1364, 2023 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36876740
2.
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.
N Engl J Med
; 380(11): 1022-1032, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865796
3.
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial.
JAMA
; 322(18): 1780-1788, 2019 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31714986
4.
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study.
Lancet
; 381(9860): 40-6, 2013 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23122768
5.
Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance.
J Clin Lipidol
; 18(1): e59-e69, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951797
6.
Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial.
JAMA Cardiol
; 9(3): 245-253, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38231501
7.
Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia.
Circulation
; 136(3): 332-335, 2017 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28716835
8.
Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials.
J Clin Lipidol
; 16(3): 286-297, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35346603
9.
Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL.
J Lipid Res
; 52(1): 136-42, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20971975
10.
Iyengar Yoga versus Enhanced Usual Care on Blood Pressure in Patients with Prehypertension to Stage I Hypertension: a Randomized Controlled Trial.
Evid Based Complement Alternat Med
; 2011: 546428, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-19734256
11.
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.
N Engl J Med
; 356(2): 148-56, 2007 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-17215532
12.
Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome.
Arterioscler Thromb Vasc Biol
; 29(1): 140-6, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18988892
13.
Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials.
J Clin Lipidol
; 14(5): 649-659.e6, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32980290
14.
Evaluating the effect of bempedoic acid on kidney function: call for cautious implementation - Authors' reply.
Lancet Diabetes Endocrinol
; 12(4): 228-229, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514239
15.
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance.
J Am Heart Assoc
; 8(7): e011662, 2019 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30922146
16.
Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial.
J Am Coll Nutr
; 27(1): 65-74, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18460483
17.
Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.
N Engl J Med
; 350(15): 1505-15, 2004 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-15071125
18.
Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome.
Arterioscler Thromb Vasc Biol
; 26(3): 624-30, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16357312
19.
Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome.
Arterioscler Thromb Vasc Biol
; 26(1): 182-8, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16284192
20.
Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled Trial.
Clin Transl Sci
; 10(6): 455-469, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28795506